Background {#Sec1}
==========

Before the 1950s, death was only determined using cardiovascular criteria. Due to advances in critical care medicine, especially mechanical ventilation, a new clinical state was observed in 1958 (i.e., "coma dépassé") \[[@CR1]\]. Although the systemic circulation was intact, the brain showed no objective evidence of function. This observation gave rise to the question of what "coma dépassé" meant. The successful transplantation of kidneys from a "coma dépassé" patient (1965) subsequently led to the first accepted standard for the confirmation of brain death in 1968 \[[@CR2]\]. In 1981, the Uniform Determination of Death Act made death determined by neurological and cardiovascular criteria equivalent \[[@CR3]\]. The American Academy of Neurology (AAN) in 1995 published guidelines for brain death determination (BDD) \[[@CR4]\], and updated these in 2010 \[[@CR5]\]. In 2008, the Academy of Medical Royal Colleges in the United Kingdom (UK) provided broader guidance on the determination of death in a range of circumstances, including BDD \[[@CR6]\].

Brain death and postmortem organ donation are closely linked. Also, an important, and not well investigated, issue regarding circulatory arrest organ donation is the hands-off time after circulatory arrest. Practices around all of these mentioned topics are delicate. Thus, inconsistencies between centers can be confusing for the general public, and could expose clinicians to accusations of unethical practice. Consensus regarding practices around brain death and postmortem organ donation could prevent these inconsistencies. To facilitate this consensus, the first step is to document potential differences.

The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI, [www.center-tbi.eu](http://www.center-tbi.eu)) study addressed this issue. The CENTER-TBI study used questionnaires to create "provider profiles" of participating neurotrauma centers. One of these questionnaires intended to address specific practices around brain death and postmortem organ donation that currently provoke international discussion. Using this questionnaire, we aimed to quantify and understand potential differences, and provide impetus for current dialogs toward further harmonization of practices around brain death and postmortem organ donation. Regarding brain death, we investigated: criteria used for BDD; and the necessity of BDD before withdrawing life-sustaining measures (LSM). As for postmortem organ donation, we investigated: removal of the ventricular drain while continuing other LSM; the possibility for circulatory arrest organ donation; and the hands-off time after circulatory arrest.

Methods {#Sec2}
=======

CENTER-TBI and study sample {#Sec3}
---------------------------

The CENTER-TBI study includes a prospective observational study on traumatic brain injury (TBI) \[[@CR7], [@CR8]\]. The investigators connected to this study collect data on patient characteristics, management, and outcomes in important centers from 20 countries across Europe and Israel. Investigators from all participating centers in the CENTER-TBI study were asked to complete several questionnaires. Centers were located in Austria (*N* = 2), Belgium (*N* = 4), Bosnia and Herzegovina (*N* = 2), Denmark (*N* = 2), Finland (*N* = 2), France (*N* = 7), Germany (*N* = 4), Hungary (*N* = 2), Israel (*N* = 2), Italy (*N* = 8), Latvia (*N* = 3), Lithuania (*N* = 2), the Netherlands (*N* = 7), Norway (*N* = 3), Romania (*N* = 1), Serbia (*N* = 1), Spain (*N* = 4), Sweden (*N* = 2), Switzerland (*N* = 1), and the UK (*N* = 8).

Questionnaire development and administration {#Sec4}
--------------------------------------------

More detailed information about the development, administration, and content of the questionnaires is available from an earlier publication by Cnossen et al. \[[@CR9]\].

The topics covered in the current study are summarized in Table [1](#Tab1){ref-type="table"}. A complete overview of the questionnaires for this study can be found in Additional file [1](#MOESM1){ref-type="media"}: Questionnaire 1 (questions 1, 4, 8, and 9), 7 (questions 2 and 4), and 8 (questions 9 and 11--15). In the questionnaires, we explicitly asked for the "general policy" according to the investigators. We defined this as the local standards used in more than 75% of patients, recognizing that there might be exceptions. Most questions made use of categorical answer categories. For some questions, the investigators had the option to fill in an answer that could be different from one of the options provided. These answers were marked as "other" and consisted of free text responses. Where these free text responses from different investigators were sufficiently similar, we sought to combine them to provide additional categorical responses. We did this to facilitate summary descriptive statistics.Table 1Topics covered, related questions for each topic, and response rate per questionTopics covered in this studyQuestions related to this topicResponse rate, *N* (%)Practices around brain death Criteria for BDDWhen do you declare a patient brain dead?67 (99%) Brain death and withdrawal of LSMMust the patient, who is not suitable for organ donation, be declared brain dead before withdrawing life-sustaining measures?67 (99%)Practices around postmortem organ donation Donation after circulatory deathWould you consider organ donation after circulatory arrest in a patient in whom mechanical ventilation will be withdrawn, but who is not brain dead?66 (97%) Ventricular drain removal and organ donationIf the decision is made to withdraw life-sustaining measures, in a patient with high intracranial pressure, but who is not brain dead, would you remove the ventricular drain (for CSF drainage), but continue other life-sustaining measures in the hope that the patient will become brain dead and thereby becomes a suitable candidate for organ donation?67 (99%) Declaration of death and hands-off time in donors and nondonorsAfter withdrawal of mechanical ventilation and after circulatory arrest, when exactly do you declare the patient dead in case of a circulatory death organ donor?64 (94%)After withdrawal of mechanical ventilation and after circulatory arrest, after how many minutes circulatory arrest do you declare the patient dead in cases not suitable as organ donor?66 (97%)*BDD* brain death determination, *CSF* cerebrospinal fluid, *LSM* life-sustaining measures

Analyses {#Sec5}
--------

We used descriptive statistics to describe our outcomes. We calculated frequencies and percentages for all variables related to the number of responses for that question. Centers at which the investigator did not respond to every question remained in our study, in order to keep groups for descriptive statistics as large as possible. The response rates per question are presented in Table [1](#Tab1){ref-type="table"}. We grouped countries into seven regions: Baltic States (Latvia and Lithuania), Eastern Europe (Bosnia and Herzegovina, Hungary, Romania, and Serbia), Israel, Northern Europe (Denmark, Finland, Norway, and Sweden), Southern Europe (Italy and Spain), the United Kingdom, and Western Europe (Austria, Belgium, France, Germany, the Netherlands, and Switzerland). We examined potential differences between and within regions.

Results {#Sec6}
=======

Center characteristics {#Sec7}
----------------------

Of the 68 centers, investigators from 67 centers participated in the questionnaires (response rate: 99%) and were included in the analysis. The participating centers were mainly academic centers (*N* = 61, 91%), designated as a level I or II trauma center (*N* = 49, 73%). The average number of beds in the participating centers was 1187, of which on average 39 were intensive care unit (ICU) beds. The average number of annual treatments per ICU in 2013 was 1408, of which on average 130 were TBI patients.

Practices around brain death {#Sec8}
----------------------------

### When do you declare a patient brain dead? {#Sec9}

We found agreement on the clinical evaluation (prerequisites and neurological assessment) for BDD in 100% of the centers. The clinical evaluation for BDD included: a Glasgow Coma Scale (GCS) of three, absence of brain stem reflexes, no respiratory efforts in response to an apnea test, and absence of confounding factors to evaluate consciousness (e.g., hypothermia). However, ancillary tests were required for BDD in 43 (64%) centers (Table [2](#Tab2){ref-type="table"}).Table 2Practices around brain deathRegionAnswerSample total\
(*N* = 67)Baltic States\
(*N* = 5)Eastern Europe\
(*N* = 6)Israel\
(*N* = 2)Northern Europe\
(*N* = 9)Southern Europe\
(*N* = 12)United Kingdom\
(*N* = 8)Western Europe\
(*N* = 25)When do you declare a patient brain dead? With GCS 3, fixed dilated pupils, and no confounding factors (e.g., hypothermia, barbiturates)00000000 With GCS 3 and absent brain stem reflexes, and no confounding factors00000000 With GCS 3, absent brain stem reflexes and apnea, and no confounding factors31201707808820 With GCS 3, absent brain stem reflexes, apnea and ancillary test(s) (e.g., EEG or cerebral angiography), and absence of confounding factors64808310022100072 Per national protocol^a^400000138Must the patient, who is not suitable for organ donation, be declared brain dead before withdrawing LSM? No, the prospect of a very poor prognosis can be enough610170784210080 No, GCS 3 and fixed dilated pupils and no confounders is enough to stop treatment130050228020 Yes, this is mandatory by law in my country1880175005000 Yes, it is not mandatory by law, but I always do that to be sure7206700000Data presented as percentage*EEG* electroencephalography, *GCS* Glasgow Coma Scale, *LSM* life-sustaining measures^a^Additional categorical responses, while free text responses were sufficiently similar. This does not mean that the other centers do not follow their national protocol

In three regions (43%; Israel, Southern Europe, and the UK), the same criteria for BDD were used in every center of the same region. In centers from Northern Europe and the UK, ancillary tests were rarely used for BDD (*N* = 2, 22% and *N* = 0, 0%, respectively).

### Must the patient, who is not suitable for organ donation, be declared brain dead before withdrawing LSM? {#Sec10}

The declaration of brain death in nondonor patients was mandatory before withdrawing LSM in 12 (18%) centers. In 41 (61%) centers, a poor prognosis as assessed by the treating physician(s) was considered sufficient. In 9 (13%) centers, a GCS score of three, fixed dilated pupils, and absence of confounders could motivate withdrawing LSM (Table [2](#Tab2){ref-type="table"}).

In all centers in the Baltic States (*N* = 5), nondonor patients were declared brain dead before withdrawing LSM. In several centers in Eastern Europe and Southern Europe (*N* = 1, 17% and *N* = 6, 50%, respectively), it was mandatory to declare a patient brain dead before withdrawing LSM in nondonor patients, whereas in other centers from the same region this was not mandatory.

Practices around postmortem organ donation {#Sec11}
------------------------------------------

### Would you consider organ donation after circulatory arrest in a patient in whom mechanical ventilation will be withdrawn, but who is not brain dead? {#Sec12}

Organ donation after circulatory arrest was forbidden in 30 (45%) centers (Fig. [1](#Fig1){ref-type="fig"} and Table [3](#Tab3){ref-type="table"}).Fig. 1Results of question 13 (Questionnaire 8): Would you consider organ donation after circulatory arrest in a patient in whom mechanical ventilation will be withdrawn, but who is not brain dead?Table 3Practices around circulatory arrest organ donation and ventricular drain removalRegionAnswerSample total\
(*N* = 66)Baltic States\
(*N* = 5)Eastern Europe\
(*N* = 6)Israel\
(*N* = 2)Northern Europe\
(*N* = 9)Southern Europe\
(*N* = 12)United Kingdom\
(*N* = 8)Western Europe\
(*N* = 24)Would you consider organ donation after circulatory arrest in a patient in whom mechanical ventilation will be withdrawn, but who is not brain dead? No, this is forbidden in my country458067506742042 No, although it would be permitted, I would not do this1520330223304 Yes, sometimes20005011251329 Yes, always20000008825Sample total\
(*N* = 67)Baltic States\
(*N* = 5)Eastern Europe\
(*N* = 6)Israel\
(*N* = 2)Northern Europe\
(*N* = 9)Southern Europe\
(*N* = 12)United Kingdom\
(*N* = 8)Western Europe\
(*N* = 25)If the decision is made to withdraw life-sustaining measures, in a patient with high intracranial pressure, but who is not brain dead, would you remove the ventricular drain (for CSF drainage), but continue other life-sustaining measures in the hope that the patient will become brain dead and then becomes a suitable candidate for organ donation? No, never33803300178828 Yes, sometimes512050100100501348 Yes, always160170033024Data presented as percentage*CSF* cerebrospinal fluid

In all centers in the UK (*N* = 8), postmortem organ donation after circulatory arrest was approved. In centers in the Baltic States, Eastern Europe, and Northern Europe, organ donation after circulatory arrestwas often forbidden (*N* = 4, 80%; *N* = 4, 67% and *N* = 6, 67% respectively).

### If the decision is made to withdraw life-sustaining measures, in a patient with high intracranial pressure, but who is not brain dead, would you remove the ventricular drain (for CSF drainage), but continue other life-sustaining measures in the hope that the patient will become brain dead and thereby becomes a suitable candidate for organ donation? {#Sec13}

In 45 (67%) centers, the ventricular drain was sometimes or always removed. In 11 of these 45 centers (16% of the Sample total), the ventricular drain was always removed while continuing other LSM. In 22 (33%) centers, the ventricular drain was never removed while continuing other LSM (Fig. [2](#Fig2){ref-type="fig"} and Table [3](#Tab3){ref-type="table"}).Fig. 2Results of question 9 (Questionnaire 8): If the decision is made to withdraw life-sustaining measures, in a patient with high intracranial pressure, but who is not brain dead, would you remove the ventricular drain (for CSF drainage), but continue other life-sustaining measures in the hope that the patient will become brain dead and thereby becomes a suitable candidate for organ donation?

In 4 (80%) centers in the Baltic States and in 7 (88%) centers in the UK, the ventricular drain was never removed. In all centers from Israel (*N* = 2) and Northern Europe (*N* = 9), the ventricular drain was "sometimes" removed.

### After withdrawal of mechanical ventilation and after circulatory arrest, when exactly do you declare the patient dead in case of a circulatory death organ donor, and in cases not suitable as an organ donor? {#Sec14}

In the case of a circulatory death organ donor, it was most common (*N* = 15, 23%) to declare the patient dead after 5-min "flatliner-ECG". In cases not suitable as an organ donor, it was most common (*N* = 21, 32%) to declare the patient dead directly after detection of a "flatliner-ECG" on the monitor (Table [4](#Tab4){ref-type="table"}).Table 4Practices around the hands-off time after circulatory arrestRegionAnswerSample total\
(*N* = 64)Baltic States\
(*N* = 5)Eastern Europe\
(*N* = 6)Israel\
(*N* = 2)Northern Europe\
(*N* = 9)Southern Europe\
(*N* = 12)United Kingdom\
(*N* = 8)Western Europe\
(*N* = 22)After withdrawal of mechanical ventilation and after circulatory arrest, when exactly do you declare the patient dead in case of a circulatory death organ donor? Directly after circulatory arrest determined after a "flatliner-ECG" on the monitor1640050118023 After 1-min "flatliner-ECG" indicating circulatory arrest500500805 After 2-min "flatliner-ECG"20000005 After 5-min "flatliner-ECG"232033011175023 After 10-min "flatliner-ECG"5201700005 After loss of pulsatile arterial curve on the invasive arterial blood pressure tracing6201700009 After 20-min "flatliner-ECG"^a^1100005800 Not done in our hospital/country^a^190170780018 Other, please specify^b^140170085014Sample total\
(*N* = 66)Baltic States\
(*N* = 5)Eastern Europe\
(*N* = 6)Israel\
(*N* = 2)Northern Europe\
(*N* = 9)Southern Europe\
(*N* = 12)United Kingdom\
(*N* = 8)Western Europe\
(*N* = 24)After withdrawal of mechanical ventilation and after circulatory arrest, after how many minutes circulatory arrest do you declare the patient dead in cases **not** suitable as organ donor? Directly after circulatory arrest determined after a "flatliner-ECG" on the monitor32401710011171350 After 1-min "flatliner-ECG" indicating circulatory arrest500000013 After 2-min "flatliner-ECG"00000000 After 5-min "flatliner-ECG"232017022253821 After 10-min "flatliner-ECG"620330000 After loss of pulsatile arterial curve on the invasive arterial blood pressure tracing62033011000 After 20-min "flatliner-ECG"^a^900005000 Not done in our hospital/country^a^800033008 Other, please specify^c^12000220508Data presented as percentage*EEG* electroencephalography^a^Additional categorical responses, while free text responses were sufficiently similar^b^Specifications filled in under "other": "two minutes after loss of pulsatile arterial curve on the invasive arterial blood pressure tracing"; "after 3 min"; "No carotid pulses and apnoea"; "absence central pulse for 5 mins confirmed by observation for further 5 mins"; "National guidance 5 mins mechanical asystole"; "apnea test positivity"; "according to the Dutch law on organ donation"; "Protokollbogen zur Feststellung des irreversiblen Hirnfunktionsausfalls"; "at the beginning of the commission observation (6 h before)"^c^Specifications filled in under "other": "Control 10 min later"; "After clinical death diagnosis: listen to heart sound, examination of pupils"; "At decision of the physician"; "No carotid pulses and apnoea"; "absence central pulse for 5 mins confirmed by observation for further 5 mins"; "apnea test positivity"; "according to the Dutch law on organ donation"; "Protokollbogen zur Feststellung des irreversiblen Hirnfunktionsausfalls"; "at the beginning of the commission observation (6 h before)"

In all centers in Israel, nondonor patients were declared dead directly after detection of a "flatliner-ECG" on the monitor. No other region had the same answer in every center concerning the declaration of death in donor and nondonor patients.

Discussion {#Sec15}
==========

We aimed to investigate specific practices that currently provoke international discussion in the area of brain death and postmortem organ donation. We aimed to quantify and understand potential differences, and provide impetus for current dialogs toward further harmonization of practices around brain death and postmortem organ donation.

Taking all results together, we found agreement on the clinical evaluation (prerequisites and neurological assessment) for brain death determination (BDD) across regions. In addition to this clinical evaluation, ancillary tests were required for BDD in 64% of the centers. BDD was deemed mandatory before withdrawal of life-sustaining measures (LSM) even outside the context of organ donation in 18% of the centers. As for practices around postmortem organ donation across regions, in 67% of the centers a ventricular drain was sometimes or always removed while other LSM were continued. Last, in 45% of the centers organ donation after circulatory arrest was forbidden.

We found important agreement and some differences regarding practices around brain death. Due to the broad categorical answer possibilities provided, the application of these findings is limited. First, agreement existed in all centers on the clinical evaluation for BDD, namely a Glasgow Coma Scale (GCS) of three, absence of brain stem reflexes, no respiratory efforts in response to an apnea test, and absence of confounding factors to evaluate consciousness. This is promising, in the light of recent calls to reach a worldwide consensus on how to determine brain death \[[@CR10]\]. However, in addition to this clinical evaluation, ancillary tests were reported to be required for BDD in two thirds of centers. These differences in the use of ancillary tests are in line with previous literature \[[@CR11]--[@CR19]\]. Interestingly, however, there have been calls to abandon ancillary tests for BDD \[[@CR20]\]. In the majority of centers from Northern Europe and the United Kingdom (UK), ancillary tests were not mandatory for BDD. This is in line with the study by Wahlster et al. \[[@CR11]\]. These discrepancies may suggest differences in ethical principles and regulatory practice between centers. In some centers it was mandatory to declare nondonor patients brain dead before withdrawing life-sustaining measures (LSM). Withdrawal of LSM and the declaration of brain death are two different processes. The obligation of BDD before limiting treatment is debatable, since many non-brain dead patients may have a hopeless prognosis rendering further treatment futile.

We also found differences regarding practices around postmortem organ donation. First, we found differences concerning the removal of the ventricular drain. Our questionnaire did not assess in-depth the reasons why some centers opted to discontinue drainage and remove the ventricular drain as compared to maintaining the device in place, and how such continued intervention was incorporated into the care plan. Second, we found differences with regard to the possibility for organ donation after circulatory arrest. These results are in line with previous literature \[[@CR21], [@CR22]\]. The ventricular drain (mentioned earlier in this paragraph) seemed to be removed more often in centers where donation after circulatory arrest was not possible. If this turns out to be general practice, this might indicate the need for reevaluation of organ donation after circulatory arrest in order to prevent future burdensome care. For international figures on donation and transplantation, we refer the reader to the Newsletter Transplant 2017 produced by the Council of Europe of the European Committee \[[@CR23]\]. There are no specific figures available for the centers involved in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. Although the CENTER-TBI study includes important neurotrauma centers, we do not know to what extent these centers are responsible for the investigated figures of the Council of Europe. For the countries involved in our study, the number of donations after brain death in 2016 varied between 1.3 per million inhabitants (Bosnia and Herzegovina) and 33.1 per million inhabitants (Spain) \[[@CR23]\]. Third, we found differences in hands-off times needed after circulatory arrest in order to declare a patient dead. This could indicate a lack of clear evidence on the exact time needed to be sure the brain has irreversibly lost its function.

Some of the differences appear region specific, but for other aspects we found variation between centers within a single region. Differences were even noted between regions participating in Eurotransplant, an organization that aims to optimally distribute organs by transplanting across national borders, when no matching recipient is available on the waiting list in the donor's country. Eurotransplant covers part of Europe, and includes eight countries: Austria, Belgium, Croatia, Germany, Hungary, the Netherlands, Luxembourg, and Slovenia. The differences found pertained to all topics covered in this study.

Present-day medicine is said to be affected by the cultural climate of the society in which it exists \[[@CR24]\]. This may indicate that differences in culture could explain some of the observed variation. Other results, such as possibilities for organ donation after circulatory arrest, suggest that variations have a more legal or regulatory basis. Observed within-region differences which suggest a more legal or regulatory basis raise questions regarding the level of enforcement of pertinent laws, and may indicate a lack of knowledge, regulatory implementation, or ambiguous legislation.

This study has several limitations that should be considered when interpreting the results. First, the participating neurotrauma centers represent a select group. The data obtained may therefore not be representative for all neurotrauma centers within the geographical areas studied. Second, our sample size made it difficult to apply more advanced statistics, such as a chi-square test, cluster analysis, and multidimensional scaling. Third, the results are based on the perceptions of practices reported by specific investigators rather than on clinical data. The CENTER-TBI study will further clarify actual practices around brain death and postmortem organ donation by analyzing clinical data. Fourth, investigators may have interpreted some questions incorrectly because a questionnaire does not always permit the nuances appropriate for clinical practice. In clinical practice, potential alternative options are both more numerous and complex than can be captured by a questionnaire. Last, investigators may have presented (even unwittingly) a more favorable image or presented individual preferences instead of the general policy in a center that we asked for.

Future research should focus on extending this study to a larger group of neurotrauma centers across the world in order to examine (in more advanced statistics) whether our results also apply to other centers. Furthermore, it would be interesting to study the origin of the differences found (e.g., cultural differences and differences pertaining to legislation). The complexity of some of the drivers of reported practice makes the case for mixed methods approaches to this problem, with a potentially substantive role for qualitative research methods. These strategies are important in order to inform preferred approaches to improve harmonization in neurotrauma centers across Europe and Israel.

Most importantly, current dialogs should be continued, and we hope that our findings may provide a basis toward further harmonization of practices around brain death and postmortem organ donation.

Conclusion {#Sec16}
==========

This study showed both agreement and some regional differences regarding practices around brain death and postmortem organ donation. We hope our results help quantify and understand potential differences, and provide impetus for current dialogs toward further harmonization of practices around brain death and postmortem organ donation.

Additional file
===============

 {#Sec17}

Additional file 1:Provider profiling questionnaires used for this study (Questionnaires 1, 7, and 8). (PDF 596 kb)

AAN

:   American Academy of Neurology

BDD

:   Brain death determination

CENTER-TBI

:   Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury

CSF

:   Cerebrospinal fluid

ECG

:   Electrocardiography

GCS

:   Glasgow Coma Scale

ICU

:   Intensive care unit

LSM

:   Life-sustaining measures

TBI

:   Traumatic brain injury

UK

:   United Kingdom
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